Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Celgene partners with Juno Therapeutics on Cancer therapies announcing $1 billion investment
Wednesday, July 01, 2015Celgene Corp on Monday launched a year partnership with Juno Therapeutics announcing a billion investment aimed at bringing to market Juno technologies that harness the immune system to treat cancer and autoimmune diseases The biotech companies in...
Roche looks to expand with its multiple sclerosis drug meeting targets in final-stage clinical trials
Wednesday, July 01, 2015Finalstage trials show efficacy of ocrelizumab vs Rebif Roche plans to seek regulatory approval in Q Sales forecast to hit nearly mln by A drug being developed by Roche to treat multiple sclerosis MS met its main targets in two finalstage cl...
Drugmakers warn Greek of medicine supply shortages if Europe's lethargy continues
Wednesday, July 01, 2015Drugmakers said on Monday they would continue to ship medicines to Greece in coming weeks despite mounting unpaid bills but warned supplies could be in jeopardy if Europe did not take emergency action In the worstcase scenario of Grexit we believe t...
Celgene to invest $1 billion in Juno to partner in cancer therapies
Tuesday, June 30, 2015Celgene Corp on Monday launched a year partnership with Juno Therapeutics announcing a billion investment aimed at bringing to market Juno technologies that harness the immune system to treat cancer and autoimmune diseases The biotech companies in...
Vitae-Boehringer diabetes drug fails as add-on therapy in trial
Tuesday, June 30, 2015Vitae Pharmaceuticals Inc said its diabetes drug failed to significantly reduce blood sugar levels of patients when used as an addon therapy raising questions about the drugs potential Vitaes shares fell as much as percent on Monday before paring s...
Novartis buys pain drug firm Spinifex for $200 mln upfront
Monday, June 29, 2015Swiss drugmaker Novartis AG boosted its presence in pain management on Monday by agreeing to buy USAustralian biotech firm Spinifex Pharmaceuticals the companies said in separate statements on Monday Spinifex said Novartis was paying million upfron...
Indian pharma's struggle to tighten standards paves way for M&A deals
Monday, June 29, 2015Indias smaller generic drugmakers struggling to cope with a bruised reputation and tougher regulation in the United States are under pressure to consider branching out to new lessprofitable markets or sell out to larger rivals Two years after its mo...
Celladon to suspend development of gene-therapy drug
Saturday, June 27, 2015Celladon Corp said it would suspend further development of its genetherapy drug for heart failure months after the treatment failed a midstage trial The companys shares fell percent to in premarket trading Celladon also announced a second reducti...
Santhera drug gets CHMP recommendation
Friday, June 26, 2015Santhera Pharmaceuticals said the European Medicines Agencys Committee for Medicinal Products for Human Use CHMP had recommended approving its Raxone drug for treating Lebers Hereditary Optic Neuropathy LHON We are very excited about the CHMPs posit...
Valeant Pharmaceuticals Makes Takeover Approach to Zoetis
Friday, June 26, 2015Valeant Pharmaceuticals International Inc has made a preliminary approach to buy animalhealth giant Zoetis Inc people familiar with the matter said in a move that could presage a big deal in yet another corner of the healthcare industry Zoetis which...
